Trial intelligence / Profile preview

Oregano extract vs Hydrocortisone in pediatric AD

NCT02289989Terminated

Sponsor
Rutgers University
Start
Nov 2014
Primary completion
Jan 2017
Countries
1
01

Overview

Randomised, double-blind trial in atopic dermatitis (AD) (2 arms), sponsored by Rutgers University. Primary endpoints: Clinical Efficacy Rated by the Patient or Caregiver at Day 25, Change of the Clinical Efficacy Rated by a Study Physician at Day 28 and 1 more. Started Nov 2014; status: terminated.

02

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT02289989.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02289989.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call